Cross-referencing clinical data
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Rosarin has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
Rosarin is not a standalone ingredient in most products. It is one of three related cinnamyl alcohol glycosides that are measured together as the rosavins fraction used to standardise Rhodiola rosea extracts. Anyone reading a label that lists three percent rosavins is looking at rosarin plus rosavin plus rosin, not one compound. The three travel together because they share a biosynthetic route in the plant.
Both are commonly taken in the morning for alertness, so they stack in practice whether or not they stack pharmacologically. There is no established shared receptor between the two, and the combination has not been characterised for the isolated glycoside. Someone sensitive to stimulants may find the pairing more activating than either alone. This is a practical caution, not a demonstrated interaction.
The pairing is a formulation convention in nootropic and stress-support blends rather than a characterised biochemical interaction. Nothing in the rosarin literature speaks to the combination. It appears here so a reader sees why the two turn up together on labels. Read it as formulation practice.
Nothing specific on file for Rosarin. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.These are the studies our verdict leans on, chosen from the 1 we read for Rosarin. The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.